Woiwode Thomas 4
4 · Tempest Therapeutics, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Woiwode Thomas
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-06-17+3,500→ 3,500 totalExercise: $2.08Exp: 2032-06-16→ Common Stock (3,500 underlying)
Footnotes (1)
- [F1]Vests over one (1) year, with one hundred per cent (100%) of the award vesting on the first anniversary of the date of grant subject to the reporting person's continuous service through the vesting date.